These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 87134)

  • 1. Maternal serum alpha-fetoprotein screening: a cost-benefit analysis.
    Layde PM; von Allmen SD; Oakley GP
    Am J Public Health; 1979 Jun; 69(6):566-73. PubMed ID: 87134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results and benefits of a maternal serum alpha-fetoprotein screening program.
    Milunsky A; Alpert E
    JAMA; 1984 Sep; 252(11):1438-42. PubMed ID: 6206249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal serum alpha-fetoprotein screening: benefits, risks, and costs.
    Campbell TL
    J Fam Pract; 1987 Nov; 25(5):461-7. PubMed ID: 2445897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antenatal screening in Oxford for fetal neural tube defects.
    Wald NJ; Cuckle HS; Boreham J; Brett R; Stirrat GM; Bennett MJ; Turnbull AC; Solymar M; Jones N; Bobrow M; Evans CJ
    Br J Obstet Gynaecol; 1979 Feb; 86(2):91-100. PubMed ID: 85462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early pregnancy screening for neural tube defects in Israel.
    Legum C; Shomrat R; Yedwab G; Jaffa AJ; Rudick A
    Isr J Med Sci; 1986; 22(3-4):210-4. PubMed ID: 2427475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal serum alpha-fetoprotein screening for the detection of neural tube defects.
    Crandall BF; Robertson RD; Lebherz TB; King W; Schroth PC
    West J Med; 1983 Apr; 138(4):524-30. PubMed ID: 6191442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal serum alpha-fetoprotein screening in a provincial Health District.
    Woolfson J; Holt EM; Whyman AE; Mabbs DV
    Br J Obstet Gynaecol; 1979 Feb; 86(2):87-90. PubMed ID: 85461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-justification analysis of prenatal maternal serum alpha-feto protein screening.
    Taplin SH; Thompson RS; Conrad DA
    Med Care; 1988 Dec; 26(12):1185-202. PubMed ID: 2462141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is maternal alpha-fetoprotein screening still of value in a low-risk area for neural tube defects?
    Hooker JG; Lucas M; Richards BA; Shirley IM; Thompson BD; Ward RH
    Prenat Diagn; 1984; 4(1):29-33. PubMed ID: 6203108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of maternal serum alpha-fetoprotein screening on antenatal diagnosis.
    Brock DJ
    Br Med J (Clin Res Ed); 1982 Jul; 285(6338):365-7. PubMed ID: 6178461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for fetal malformations using ultrasound and measurements of alpha-fetoprotein in maternal serum.
    Persson PH; Kullander S; Gennser G; Grennert L; Laurell CB
    Br Med J (Clin Res Ed); 1983 Mar; 286(6367):747-9. PubMed ID: 6186332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parent preferences and prenatal testing for neural tube defects.
    Ennever FK; Lave LB
    Epidemiology; 1995 Jan; 6(1):8-16. PubMed ID: 7534119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Dual positivity' for neural tube defects and down syndrome at maternal serum screening: gestational outcome.
    Zanini R; Tarantini M; Cerri V; Jacobello C; Bellotti D; Lancetti S; Scalchi S; Groli C; Bianchi UA
    Fetal Diagn Ther; 1998; 13(2):106-10. PubMed ID: 9650657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When does mass screening for open neural tube defects in low-risk pregnancies result in cost savings?
    Tosi LL; Detsky AS; Roye DP; Morden ML
    CMAJ; 1987 Feb; 136(3):255-65. PubMed ID: 2433011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. alpha-Fetoprotein screening.
    Burton BK
    Adv Pediatr; 1986; 33():181-96. PubMed ID: 2432763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal serum alpha fetoprotein testing: some public policy considerations.
    Kasper AS
    Women Health; 1981; 6(1-2):147-53. PubMed ID: 11650640
    [No Abstract]   [Full Text] [Related]  

  • 18. Maternal serum alpha-fetoprotein screening: promise not yet fulfilled.
    Nadler HL; Simpson JL
    Am J Obstet Gynecol; 1979 Sep; 135(1):1-2. PubMed ID: 89812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal serum alpha-fetoprotein monitoring. Council on Scientific affairs.
    JAMA; 1982 Mar; 247(10):1478-81. PubMed ID: 6173496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal diagnosis policy without routine amniocentesis in pregnancies with a positive family history for neural tube defects.
    Papp Z; Tóth Z; Török O; Szabó M
    Am J Med Genet; 1987 Jan; 26(1):103-10. PubMed ID: 2433941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.